Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
This article addresses a recent decision of a New York state appellate court concerning the admissibility of expert medical testimony to establish causation in a case involving injuries allegedly incurred from treatment with a prescription medication. In Zito v. Zabarsky, 28 A.D.3d 42 (2d Dep't Jan. 24, 2006), the appellate court held that expert testimony that a plaintiff's injury was caused by a prescription medication was admissible when that testimony was based on a single case report indicating a link between the medication and the injury. The court's holding is inconsistent with other New York appellate decisions addressing the admissibility of expert testimony concerning medical causation and threatens to dilute New York's standard for making that assessment, and could have the same effect in other states that apply the same standard.
New York state courts apply the standard set forth in Frye v. United States, 293 F. 1013 (D.C. Cir. 1923), to determine the admissibility of 'novel scientific evidence.' People v. Wesley, 83 N.Y.2d 417, 422 (1994). In People v. Wernick, 89 N.Y.2d 111, 117 (1996), the state's highest court, the Court of Appeals, held that the Frye test applies 'in all instances when a party seeks to present novel scientific or … medical evidence.' (Emphasis added.) Specifically, the court held that a defendant's attempt to offer expert testimony in 'an attempt to establish a 'pattern,' 'profile,' 'theory' or 'syndrome' to show certain characteristics of women who kill their newborns immediately after birth was subject to the Frye standard. The Court of Appeals affirmed the exclusion of that 'novel hypothesis' because that theory was 'not generally recognized in the relevant medical context and community.' Id. at 115.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
On Aug. 9, 2023, Gov. Kathy Hochul introduced New York's inaugural comprehensive cybersecurity strategy. In sum, the plan aims to update government networks, bolster county-level digital defenses, and regulate critical infrastructure.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
When we consider how the use of AI affects legal PR and communications, we have to look at it as an industrywide global phenomenon. A recent online conference provided an overview of the latest AI trends in public relations, and specifically, the impact of AI on communications. Here are some of the key points and takeaways from several of the speakers, who provided current best practices, tips, concerns and case studies.
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.